Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population‐based cohort study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population‐based cohort study
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-07-06
DOI
10.1111/bcp.14056
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia
- (2018) Oriana Yu et al. AMERICAN JOURNAL OF MEDICINE
- Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities
- (2017) Rosario Pivonello et al. Pituitary
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study
- (2016) Manuj Sharma et al. BMJ Open
- Pioglitazone use and risk of bladder cancer: population based cohort study
- (2016) Marco Tuccori et al. BMJ-British Medical Journal
- Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review
- (2016) Yuehong Chen et al. Journal of Diabetes
- Pioglitazone use and risk of bladder cancer: population based cohort study
- (2016) Marco Tuccori et al. BMJ-British Medical Journal
- Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
- (2016) Seon-Ah Cha et al. Diabetes & Metabolism Journal
- State of the art paper Sulfonylureas and their use in clinical practice
- (2015) Daniele Sola et al. Archives of Medical Science
- Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2015) Silvio E. Inzucchi et al. DIABETOLOGIA
- Data Resource Profile: Clinical Practice Research Datalink (CPRD)
- (2015) Emily Herrett et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus
- (2013) Christianne L. Roumie et al. ANNALS OF INTERNAL MEDICINE
- Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA trial
- (2013) Julio Rosenstock et al. Diabetes & Vascular Disease Research
- Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy
- (2013) S. Wheeler et al. DIABETOLOGIA
- Effects of Sulfonylureas on Tumor Growth: A Review of the Literature
- (2013) G. Pasello et al. ONCOLOGIST
- Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study
- (2013) E. Herrett et al. BMJ-British Medical Journal
- Acute symptomatic hypoglycaemia mimicking ischaemic stroke on imaging: a systemic review
- (2012) Ai Wain Yong et al. BMC Neurology
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- Cardiovascular involvement in patients affected by acromegaly: An appraisal
- (2012) Susanna Mosca et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data
- (2012) Susan E. Andrade et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study
- (2011) Tina Ken Schramm et al. EUROPEAN HEART JOURNAL
- Validity of diagnostic coding within the General Practice Research Database: a systematic review
- (2010) Nada F Khan et al. BRITISH JOURNAL OF GENERAL PRACTICE
- The Association of Serum Insulin-Like Growth Factor-I with Mortality, Cardiovascular Disease, and Cancer in the Elderly: A Population-Based Study
- (2010) Christa C. van Bunderen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Validation and validity of diagnoses in the General Practice Research Database: a systematic review
- (2009) Emily Herrett et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
- (2009) Sebastian Schneeweiss et al. EPIDEMIOLOGY
- IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population
- (2008) Mikkel Andreassen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started